Platelet-rich Plasma (PRP) Treatment for Medial Retinaculum Tear Post Medial Patellar Dislocation

PRP Treatment for Medial Retinaculum Tear - Randomized-Double-Blind-Placebo Control Trail

Status

Completed

Phases

Phase 2Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00743873

Enrollment

Registered

2008-08-29

Start date

2008-01-31

Completion date

2009-03-31

Last updated

2011-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patella-Dislocation

Keywords

medial retinaculum tear s/p patella dislocation

Brief summary

To check the influence of injected platelet-rich plasma (PRP) on the healing of medial retinaculum and the redaction in recurrent dislocation of the patella.

Detailed description

Autologous platelet-rich matrices may aid in the healing of ligaments & tendons by promoting and accelerating tissue healing because of the release of growth factors including transforming growth factor (TGF)-beta1 and platelet-derived growth factor (PDGF) from platelet alpha-granules.

Interventions

BIOLOGICALPlasma Rich in Growth Factors (PRGF)

US guided IM injection 3-6mg

DRUGplacebo

injection of 6 cc of saline into injured area

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to 40 Years

Healthy volunteers

Inclusion criteria

* age 18-40 years old * first time patella dislocation

Exclusion criteria

* pregnancy * mental or physical disabilities

Design outcomes

Primary

Measure	Time frame
redaction in healing time and recurrence	1 year

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026